Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma.

Abstract

In the present study, uremic patients on chronic maintenance hemodialysis were treated with recombinant erythropoietin. Before and after 20 weeks of treatment, platelet adhesion and aggregation were studied with perfusions over a sprayed collagen surface and over matrix of cultured endothelial cells with high tissue factor activity. The influence of the… (More)

Topics

Cite this paper

@article{Zwaginga1991TreatmentOU, title={Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma.}, author={Jaap Jan Zwaginga and Martin J W Ijsseldijk and Philip G. de Groot and Mirjam Kooistra and Joseph G. Vos and Andrew van Es and Hein A. Koomans and Albert Struyvenberg and Jan J. Sixma}, journal={Thrombosis and haemostasis}, year={1991}, volume={66 6}, pages={638-47} }